Accelerated Biosciences Corp.
Tuesday, June 04, 2024
Company Presentation
![Cell and Gene Therapy and Genome Editing](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/icons/seminars/BIO-track-icon_GeneEditing_MTC.png)
Company Presentation Theater 4
Accelerated Biosciences is a regenerative medicine company with freedom-to-operate for the human Trophoblast Stem Cell (hTSC) platform with 49 patents granted. We are providing GMP cells with a complete regulatory package to help cell and gene therapy developers accelerate their product time to market by 3 to 5 years with a potential $10M in savings. We have effectively de-risked the starting cell source decision for the regenerative medicine industry. We are available for partnering and licensing opportunities.
![Accelerated Biosciences Corp.](https://www.abstractscorecard.com/uploads/Tasks/upload/21754/XDQDGWMO-1697956-1-JPG.jpg)
Company Website:
http://www.acceleratedbio.com
Lead Product in Development:
Human trophoblast Stem Cells (hTSC)
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Company HQ City
Philadelphia
Company HQ State
PA
Company HQ Country
United States
CEO/Top Company Official
Yuta Lee
Development Phase of Primary Product
Pre-Clinical
Primary Speaker